KF
ARRY

Kopp Funds’s Array Biopharma Inc ARRY Stock Holding History

Kopp Funds’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$11.2M Buy
+2,228,628
New +$12.1M 5.05% 6

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kopp Funds's ARRY Position: Q4 2013 in Review

Kopp Funds opened a new position in Array Biopharma Inc (ARRY) in Q4 2013: 2,228,628 shares worth $11.2M. The stake represents 5.05% of the portfolio and ranks #6 among its holdings.

143 funds tracked by Wall St. Rank hold ARRY as of Q4 2013.

  • Kopp Funds held 2,228,628 shares of Array Biopharma Inc worth $11.2M as of Q4 2013.
  • Array Biopharma Inc was a new Kopp Funds position in Q4 2013.
  • Array Biopharma Inc made up 5.05% of Kopp Funds's portfolio in Q4 2013, its #6 holding.
  • 143 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2013.

Based on Kopp Funds's 13F filing for Q4 2013, filed 21 Jan 2014.